X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ALEMBIC PHARMA - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ALEMBIC PHARMA DIVIS LABORATORIES/
ALEMBIC PHARMA
 
P/E (TTM) x 18.3 26.1 70.0% View Chart
P/BV x 4.0 6.0 66.4% View Chart
Dividend Yield % 1.6 0.8 197.8%  

Financials

 DIVIS LABORATORIES   ALEMBIC PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-16
ALEMBIC PHARMA
Mar-16
DIVIS LABORATORIES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs2,484792 313.7%   
Low Rs918443 207.2%   
Sales per share (Unadj.) Rs142.3167.0 85.2%  
Earnings per share (Unadj.) Rs41.938.2 109.7%  
Cash flow per share (Unadj.) Rs46.342.0 110.3%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Dividend yield (eoy) %0.60.6 90.7%  
Book value per share (Unadj.) Rs161.584.9 190.2%  
Shares outstanding (eoy) m265.47188.52 140.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x12.03.7 323.5%   
Avg P/E ratio x40.616.2 251.0%  
P/CF ratio (eoy) x36.714.7 249.7%  
Price / Book Value ratio x10.57.3 144.8%  
Dividend payout %23.910.5 227.8%   
Avg Mkt Cap Rs m451,525116,383 388.0%   
No. of employees `0003.7NA-   
Total wages/salary Rs m3,6494,214 86.6%   
Avg. sales/employee Rs Th10,184.4NM-  
Avg. wages/employee Rs Th984.1NM-  
Avg. net profit/employee Rs Th2,998.5NM-  
INCOME DATA
Net Sales Rs m37,76431,487 119.9%  
Other income Rs m84855 1,539.7%   
Total revenues Rs m38,61231,542 122.4%   
Gross profit Rs m14,13810,060 140.5%  
Depreciation Rs m1,182722 163.7%   
Interest Rs m2337 63.0%   
Profit before tax Rs m13,7819,356 147.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6622,160 123.2%   
Profit after tax Rs m11,1197,194 154.5%  
Gross profit margin %37.431.9 117.2%  
Effective tax rate %19.323.1 83.7%   
Net profit margin %29.422.8 128.9%  
BALANCE SHEET DATA
Current assets Rs m30,94715,066 205.4%   
Current liabilities Rs m5,1957,674 67.7%   
Net working cap to sales %68.223.5 290.5%  
Current ratio x6.02.0 303.4%  
Inventory Days Days11767 174.4%  
Debtors Days Days8541 209.6%  
Net fixed assets Rs m17,0278,237 206.7%   
Share capital Rs m531377 140.8%   
"Free" reserves Rs m42,34115,416 274.6%   
Net worth Rs m42,87716,005 267.9%   
Long term debt Rs m50-   
Total assets Rs m49,68424,594 202.0%  
Interest coverage x595.0255.2 233.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 59.4%   
Return on assets %22.429.4 76.3%  
Return on equity %25.944.9 57.7%  
Return on capital %32.258.7 54.9%  
Exports to sales %85.355.7 153.0%   
Imports to sales %22.910.4 219.8%   
Exports (fob) Rs m32,19817,551 183.5%   
Imports (cif) Rs m8,6543,283 263.6%   
Fx inflow Rs m32,27017,811 181.2%   
Fx outflow Rs m8,7755,318 165.0%   
Net fx Rs m23,49612,493 188.1%   
CASH FLOW
From Operations Rs m10,3799,304 111.6%  
From Investments Rs m-4,135-3,105 133.2%  
From Financial Activity Rs m-6,241-1,959 318.6%  
Net Cashflow Rs m34,240 0.1%  

Share Holding

Indian Promoters % 52.0 74.1 70.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 2.9 406.9%  
FIIs % 19.0 9.1 208.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 13.9 123.7%  
Shareholders   31,796 49,328 64.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare DIVIS LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 23, 2017 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - FDC LTD. COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS